Filing Details
- Accession Number:
- 0001447362-20-000263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 18:00:59
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-18 18:00:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239501 | J Derek Maetzold | C/O Castle Biosciences, Inc. 820 S. Friendswood Drive, Suite 201 Friendswood TX 77546 | Pres. & Chief Exec. Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-16 | 6,250 | $50.55 | 1,374,446 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-17 | 4,450 | $48.45 | 1,369,996 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-17 | 1,200 | $49.17 | 1,368,796 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-17 | 600 | $50.44 | 1,368,196 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-18 | 2,694 | $46.37 | 1,365,502 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-18 | 2,755 | $47.54 | 1,362,747 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-18 | 801 | $48.23 | 1,361,946 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 159,329 | Indirect | By trust |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020.
- This transaction was executed in multiple trades at prices ranging from $50.190 to $50.905, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $47.830 to $48.820, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $48.840 to $49.630, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $50.010 to $50.990, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $45.880 to $46.850, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $46.960 to $47.900, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $48.020 to $48.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by the DJM Grantor Retained Annuity Trust No. 1, or the Maetzold Trust. The Reporting Person is a trustee of the Maetzold Trust.
Billionaire Hedge Funds
